We evaluated, in 415 patients with asymptomatic carotid atherosclerosis: (i) the prevalence of C. pneumoniae DNA in atherosclerotic carotid plaques and peripheral blood mononuclear cells (PBMC); (ii) the distribution of C. pneumoniae in atherosclerotic carotid plaques and PBMC from the same patients; (iii) the correlation between circulating anti-chlamydial antibodies and the presence of C. pneumoniae DNA. Overall, 160 atherosclerotic carotid plaques and 174 PBMC specimens from patients with asymptomatic carotid atherosclerosis were examined by ompA nested touchdown PCR for presence of C. pneumoniae. In addition, C. pneumoniae DNA was detected in 81 specimens of atherosclerotic carotid plaque and PBMC obtained from the same patients. C. pneumoniae DNA was found in 36.9% of atherosclerotic carotid plaques and in 40.2% of PBMC specimens examined (P=NS). With regard to 81 patients, C. pneumoniae DNA was detected in 27.2% of atherosclerotic carotid plaques and in 44.4% of PBMC specimens (P=0.05). In 18 patients, the presence of C. pneumoniae DNA in PBMC specimens and atherosclerotic carotid plaques coincided (P=0.005). No statistically significant association was found between anti-C pneumoniae antibodies (IgG and IgA) and positive PCR results. In conclusion, our results suggest that the detection of C. pneumoniae DNA in PBMC specimens seems to be a first-choice method to identify the patients at risk for endovascular chlamydial infection.
O'ConnorS., TaylorC., CampbellL.A., EpsteinS. and LibbyP.2001. Potential infectious etiologies of atherosclerosis: a multifactorial perspective.Emerg. Infect. Dis.7:780.
2.
JacksonL.A., CampbellL.A., KuoC.C., RodriguezD.I., LeeA. and GraystonA.1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen.J. Infect. Dis.176:292.
3.
MaassM., BartelsC., EngelP.M., MamatU. and SieversH.H.1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.J. Am. Coll. Cardiol.31:827.
4.
ApfalterP., LoidlM., NadrchalR., MakristathisA., RotterM., BergmannM., PolteraurerP. and HirschlA.M.2000. Isolation and continuous growth’ of Chlamydia pneumoniae from arterectomy specimens.Eur. J. Clin. Microbiol. Infect. Dis.19:305.
5.
GaydosC. A. and QuinnT.C.2000. The role of Chlamydia pneumoniae in cardiovascular disease.Adv. Intern. Med.45:139.
6.
SaikkuP., LeinonenM., MattilaK., EkmanM.R., NieminenM.S., MakelaP.H., HuttunenJ.K. and ValtonenV.1988. Serological evidence of an association of novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.Lancet2:983.
7.
SessaR., Di PietroM., SantinoI., del PianoM., VarveriA., DagiantiA. and PencoM.1999. Chlamydia pneumoniae infection and atherosclerotic coronary disease.Am. Heart J.137:1116.
8.
BomanJ. and HammerschlagM.R.2002. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.Clin. Microbiol. Rev.15:1.
9.
RomanoS., FratiniS., Di PietroM., SchiavoniG., NicolettiM., ChiarottiF., del PianoM., PencoM. and SessaR.2004. Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up.Int. J. Immunopathol. Pharmacol.17:209.
10.
HeltaiK., KisZ., BurianK., EndreszV., VeresA., LudwingE., GonczolE. and Valyi-NagyI.2004. Elevated antibodies levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial and ischaemic heart disease.Atherosclerosis1732:339.
11.
YetkinG., YetkinE., AksoyY., GurbuzO.A. and MertA.2004. Changes in antibodies titers against Chlamydia pneumoniae after coronary angioplasty.Int. J. Cardiol.95:293.
12.
NobelM., De TorrentèA., PeterO. and GennèD.1999. No serological evidence of association between Chlamydia pneumoniae infection and acute coronary heart disease.Scand. J. Infect. Dis.31:261.
13.
DaneshJ., WhincupP., WalkerM., LennonL., ThomsonA., ApplebyP., WongY.K., Bernardes-SilvaM. and WardM.2000. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.B.M.J.321:208.
14.
DaneshJ., WhincupP., LewingtonS., WalkerM., LennonL., ThomsonA., WongY.K., ZhouX. and WardM.2002. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis.Eur. Heart J.23:371.
15.
RassuM., CazzavillanS., ScagnelliM., PeronA., BevilacquaP.A., FaccoM., BertoloniG., LauroF.M., ZambelloR. and BonoldiE.2001. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions.Atherosclerosis158:73.
16.
SessaR., Di PietroM., SchiavoniG., NicolettiM., SodaG., NardoniS., BoscoD., SantinoI., CiprianiP. and del PianoM.2004. Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries.Int. J. Immunopathol. Pharmacol.17:301.
17.
BahrmandA.R., BahadoriM., HossainiA., VelayatiA.A., AghabozorgyS., ShakoorA. and BakayevV.V.2004. Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesions.Scand. J. Infect. Dis.362:119.
18.
BomanJ., SodebergS., ForsbergJ., BirganderL. S., AllardA., PersonK., JidellE., KumlinU., JutoP., WaldenstromA. and WadellG.1998. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and middle-aged blood donors.J. Infect. Dis.78:274.
19.
SessaR., Di PietroM., SchiavoniG., SantinoI., CiprianiP., RomanoS., PencoM., DagiantiA. and del PianoM.2001. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease.Atherosclerosis159:521.
20.
SmiejaM., MahonyJ., PetrichA., BomanJ. and CherneskyM.2002. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.B.M.C. Infect. Dis.2:1.
21.
SessaR., Di PietroM., RatanaratR., RassuM. and RoncoC.2005. Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients.Int. J. Artif. Organs281:37.
22.
CochraneM., PospischilA., WalkerP., GibbsH. and TimmsP.2003. Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures.J. Clin. Microbiol.414:1454.
23.
CondosR., McCluneA., RomW.N. and SchlugerN.W.1996. Peripheral-blood based PCR assay to identify patients with active pulmonary tuberculosis.Lancet34:1082.
24.
TongC.Y.W. and SillisM.1993. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.J. Clin. Pathol.46:313.
25.
CampbellL.A., Perez-MelgosaM., HamiltonS., KuoC. C. and GraystonJ. T. h1992. Detection of Chlamydia pneumoniae by the polymerase chain reaction.J. Clin. Microbiol.30:434.
26.
Da CostaC.P., Ahmad-NejadP., SchmidM., NeumannF.J., WagnerH. and MiethkeT.2000. Low prevalence of Chlamydia pneumoniae DNA in PBMCs of coronary heart-disease patients and blood donors:. influence of treatment with roxithromycin.Proceedings of the Fourth Meeting of the European Society for Chlamydia Research.Helsinki, Finland, p. 248
27.
PragerM., TurelZ., SpeidlS.W., ZornG., KaunC., NiessnerA., HeinzeG., HukI., MaurerG., HuberK. and WojtaJ.2002. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.Stroke33:2756.
28.
BisharaJ., PitlikS., KazakovA., SaharG., HaddadM., VojdaniA., RosenbergS. and Samra2003. Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis.Eur. J. Clin. Microbiol. Infect. Dis.22:300.
29.
SessaR., Di PietroM., SchiavoniG., SantinoI., ValentiniF.B., PernaR., RomanoS. and del PianoM.2003. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease.J. Vasc. Surg.37:1027.
30.
BlasiF., BomanJ., EspositoG., MelissanoG., ChiesaR., CosentiniR., TarsiaP., TshombaY., BertiM., AlessiM., MorelliN. and AllegraL.1999. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection.J Infect Dis180:2074.
31.
BergerM., SchroderB., DaeschleinG., SchneiderW., BusjahnA., BuchwalowI., LuftC. F. and HallerH.2000. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes.J. Lab. Clin. Med.136:194.
32.
ApfalterP., BarouschW., NehrM., WillingerB., RotterM. and HirschlA.M.2004. No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction.Stroke35:2024.
33.
MaassM., GieffersJ., KrauseE., EngelP.M., BartelsC. and SolbachN.1998. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.Med. Microbiol. Immunol.187:103.
34.
LabicheR., KoziolD., QuinnT.C., GaydosC., AzharS., KetronG., SoodS. and DeGabraJ.T.2001. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque.Stroke32:855.
35.
SessaR., SchiavoniG., Di PietroM., PetruccaA., CiprianiP., ZagagliaC., FalluccaS. and del PianoM.2005. Chlamydia pneumoniae in PBMC: reproducibility of the ompA nested touchdown PCR.Int. J. Immunopathol. Pharmacol.18:113.
36.
SmiejaM., MahonyJ.B., GoldsmithC.H., ChongS., PetrichA. and CherneskyM.2001. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.J. Clin. Microbiol.39:1796.
